Clinical guideline for the prevention and treatment of osteoporosis (2024) NOGG

Description

This comprehensive clinical guideline outlines strong and conditional recommendations for the prevention and treatment of osteoporosis, covering fracture risk assessment, intervention thresholds, non-pharmacological management, specific pharmacological options (including bisphosphonates and denosumab), and strategies for managing patients with high fracture risk or receiving specific therapies (e.g., glucocorticoids, aromatase inhibitors).